Staphylococcus aureus (MRSA) is a major cause of Nosocomial, community acquired infections and neonatal sepsis. The Glycopeptide vancomycin was the drug of choice for treating infections. Aim: Identifying the vancomycin-resistance phenotypically and genotypically among the MRSA isolates from Shibin El-Kom teaching Hospital. Materials and Methods: All samples were collected from Neonatal intensive care unit (NICU) of Shibin El-Kom teaching hospital in Minoufiya, Egypt and identified by conventional methods. S aureus and MRSA were isolated and identified from different clinical samples using conventional methods confirmed by antibiogram of the isolates and mec A gene detection. vancomycin MIC and Vancomycin screening agar were determined following CLSI guidelines. Van A was amplified by PCR using standard primers. Out of the 200 neonates included in this study, 85% were positive growth and 15% were negative growth. Among them, 25% isolates were staphylococci, 42 isolates had nuc gene. Out of 42 S. aureus, 80.95% had mecA gene and 19.05% had not Mec A gene. The VRSA isolates had not van A gene. Conclusions: Vancomycin was still the most effective drug against S. aureus infection. All MRSA in Shibin El-Kom Teaching Hospital had not vanA gene.
Over the past few decades, there has been an alarming increase in the prevalence of antibiotic-resistant pathogens and strains in serious infections. The occurrence of bacterial infection had decreased with the discovery of penicillin in 1940 until Staphylococcus aureus began producing B-lactamase, which destroys the penicillin B-lactam core ring (Khan, et al., 2013) . This increase in resistance towards penicillin drove the development of methicillin drugs, which are virtually resistant against many genetic variations of the B-lactamase enzyme. Since then, MRSA has become endemic in hospitals and nursing homes worldwide (Noor & Munna, 2015) . The treatment of the S. aureus infections has become problematic because of the increase of resistance to methicillin, vancomycin and other antibiotics (Mathews et al., 2010) .
The glycopeptide vancomycin was considered to be the best alternative for the treatment of multi drug-resistant MRSA. However, there are increasing numbers of reports indicating the emergence of vancomycin-resistant S. aureus (VRSA) strains exhibiting two different resistance mechanisms. Initially, vancomycin-intermediate S. aureus (VISA) noted to be due to the thickened cell wall (Hiramatsu et al., 1997) , where many vancomycin molecules were trapped within the cell wall. The trapped molecules clog the peptidoglycan meshwork and finally form a physical barrier towards further incoming vancomycin molecules (Cui et al., 2006) The second was identical to the mechanism seen in vancomycin-resistant Enterococcus. Vancomycin-resistant Enterococcus faecium harbours the vanA operon, which contains five genes, VanS, -R, -H, -A and -X8. But Tiwari and Sen have reported a VRSA which is van gene-negative. (Tiwari and Sen 2006 ) Subsequent isolation of VISA and VRSA isolates from other countries has confirmed that the emergence of these strains is a global issue. Vancomycin was the drug of choice for treatment of infections caused by MRSA. High vancomycin MIC for MRSA which are susceptible to vancomycin may indicate the drug resistance to many antibiotics (Kshetry et al., 2016) . The vancomycin has been a high molecular weight antibiotic, does not diffuse in concentration gradient manner while diffusing through the agar medium when the disc susceptibility test is employed. Moreover, it does not differentiate between vancomycin-susceptible isolates from vancomycin-intermediate isolates of S. aureus and hence disc diffusion testing is not used for detection of VRSA (CLSI 2012).
The aim of the present study was to identify the emergence of vancomycin-resistant MRSA among S. aureus isolates from patients with Neonatal sepsis attending the Intensive Care Unit in Shibin El-Kom Teaching Hospital. Determination of MIC: MIC of vancomycin was determined by agar dilution method using CLSI guidelines (CLSI 2014). Briefly, gradient plates of Mueller-Hinton agar (Oxoid, England) were prepared with vancomycin (2-32 mg/l, Oxoid, England). 0.5 McFarland equivalent inoculum prepared using 18-24h; old culture was spotted on to gradient plates. Plates were incubated overnight at 35°C for 24h before assessing the visible growth.
Material and Methods

Study
Vancomycin screening plate: Brain heart infusion (BHI) was used for vancomycin (VA) screening plate (6µg/ml). All plates were inoculated with 10µl of an inoculum suspension prepared with growth from an overnight blood agar plate, with a turbidity equivalent to 0.5 McFarland standard. The plates were incubated for 48h, and growth was reported after both 24 and 48h (Bhateja et al., 2005) .
DNA Extraction: DNA of S. aureus isolated according to the Kit (Jena Bioscience. Germany) according to the manufacturer's recommendations. The eluted DNA was stored at -20°C until use PCr amplification for Nuc, MecA and VanA genes
Amplification was carried out according to the following thermal and cycling condition for Nuc gene ( table 1) using Gene Amp (Applied Biosystems, USA) The primers and the PCR conditions were as described by (Zhang et al., 2004) Amplified fragments were visualized on a 1% agarose gel electrophoresis stained with ethidium bromide. A DNA ladder (100-1500bp) was used to estimate allele sizes in base pairs (bp) for the gel.
results
Out of the 200 neonates had neonatal sepsis, 85% were positive growth and 15% were negative growth. Out of 85% positive growth, 35% were Gram Positive, 37.5% were Gram-Negative and (12.5%) were Candida (Tab 2). Among 70 of Gram-Positive, 50 isolates were confirmed phenotypically as S. aureus. PCR amplification confirmed the presence of nuc gene in 42(84%) of the 50 isolates (table 4). The PCR product appeared a single DNA band with a size equal to 279 bp fragments (Fig 3) . Antibiotic susceptibility tests were evaluated by the disk diffusion method for all isolates of S. aureus (Table 5 & Fig 2) . Isolates of S. aureus showed different level of resistance against some antibiotics (Fig 1) .
Among the 50 clinical isolates of S. aureus, 50(100%) were identified as methicillinresistant S. aureus (MRSA) by disc diffusion method. This was confirmed by detection of mecA gene. The PCR product appeared a single DNA band with a size equal to 310 bp fragment corresponding to the mec A gene for 34 (68%) isolates of S. aureus and 16(32%) had not mec A gene (Fig 4) .
MIC of vancomycin was determined by agar dilution method using CLSI guidelines. MIC of Vancomycin for 50 staphylococci isolates were 48 isolates sensitive for vancomycin and two isolates resistant for vancomycin in concentration 2µg/mL while 49 isolates sensitive for vancomycin and one isolate resistant for vancomycin in concentration 4 and 8µg/mL while 50 isolates sensitive for vancomycin in concentration 16 and 32µg/mL (Tab 5). By Vancomycin Screening Agar for 50 staphylococci isolates were 49 isolates sensitive for vancomycin and one isolate resistant for vancomycin (Table 6) .
The PCR amplification did not appear band corresponding to van A gene for S. aureus and 50 had not van A gene (Fig 5) .
disCussion
The present study a total of 200 samples tested, 50 isolates were staphylococci. S. aureus was identified and classified by PCR using specific primers for housekeeping genes in these bacteria, such as the nuc gene. The PCR depending on a diagnostic protocol was used to detect the different genes (Mehrotra et al., 2000) . Nuc gene is base line in identification and classification of S. aureus and in the present study, the nuc gene fragment was equal to 279 bp. Some reports indicated that the nuc gene was encoded to enzyme thermo nuclease (Brakstad et al., 1992) . By applying PCR method, among the 126 clinical samples that were identified as S. aureus with phenotypic methods, 101 (80.2%) isolates were found to be nuc positive (Roxana et al., 2014) , this agrees with our results.
Infections caused by methicillinresistant S. aureus have been associated with high morbidity and mortality rates. MRSA is one of the common causes of hospital-acquired infections and 30 to 80 percent methicillin resistance in S. aureus based on antibiotic sensitivity tests has been reported from different hospitals Anupurba et al., (2003) .
Antibiotic susceptibility testing has been found to be a good epidemiological marker for MRSA phenotyping. The present study, among MRSA isolates high degree of resistance was encountered for Ampicillin (100%), Cefoxitin (100%), Cephardine (88%), Oxacillin (84%), and Meropenem (74%). Our study similar to Mundhada et al., which also found a high level of resistance to Erythromycin (Mundhada et al., 2016) . In our study, the isolates of S. aureus revealed increasing resistance against many antibiotics, such as Cefoxitin while they appeared sensitive to other antibiotics like Vancomycin. 84% isolates of S. aureus were Oxacillin-resistant, The cefoxitin disc diffusion method was more sensitivity and specificity than other routinely methods used for detection of MRSA. This method can be preferred in clinical microbiology laboratories, because it is easy to prepare (Mundhada et al., 2016) .
S. aureus is a major causes of communityacquired and nosocomial infections .They are also among the most frequently isolated bacteria in clinical microbiology laboratories (Gosbell et al., 2001) . Simple and rapid identification and discrimination of S. aureus is detection of MET resistance is essential for prompt institution of effective antimicrobial chemotherapy and for limiting the unnecessary use of certain classes of antibiotics. Since MET resistance (encoded by mec A) are mediated by the expression of PBP2a, PCR detection of mec A is considered the "gold standard" for the detection of MET resistance (Zhang et al., 2004, Our results confirmed the presence of mec A gene among 34 (68%) isolates of S. aureus and 16(32%) had not mec A gene.
Other investigators have shown that the presence of mecA gene correlates 100% with the detection of methicillin resistance in S.aureus when it is compared with the other methods (Thompson et al., 1982) . From 126 S.aureus isolates, 87 (69%) isolates harbor the mec A gene and identified as methicillin-resistant S.aureus (MRSA) and the remaining 39 (31%) isolates were methicillinsusceptible (MSSA) (Roxana et al., 2014) . Sixty seven (83.8%) of the 80 MRSA isolates and 26.8% of the total 250 Staphylococcus aureus isolates which were tested, were found to be multidrug resistant MRSA (Rashedul et al., 2016) .
The MIC value of vancomycin indicated that all isolates were sensitive to vancomycin. The genetic mechanism of vancomycin resistance in VRSA is not well understood. Several genes have been proposed as being involved in certain clinical VRSA strains (Jansen et al., 2007) . The experimental transfer of the vanA gene cluster from E. faecalis to S. aureushas raised fears about the occurrence of such genetic transfer in clinical isolates of methicillin resistant S. aureus. In this study, all the phenotypically VRSA isolates contained mecA, but no isolates contained vanA. Tiwari & Sen (2006) have also reported a van genenegative VRSA.Results of Rana-Khara et al., showed that all strains sensitive for vancomycin (Rana-Khara et al., 2016), which agree with our result.
In conclusion, the results of this study showed the occurrence of vanA gene-negative VRSA in Egypt. Though resistance to Vancomycin among Staphylococcus aureus isolates is not found in our study, the MRSA prevalence is higher and calls for measures to control its spread in hospital and infections due to it. Moreover regular testing to detect vancomycin resistance should be carried out so that the emergence of any resistant strain is detected, especially among the MRSA strains. A large proportion of these MRSA was found to be multidrug resistant, which takes attention to strict antibiotic policy should be enforced to curtail the irrational use of antibiotics.
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